| Univariate analysis |
|
|
|
|
| Age, yrs (<50 vs. ≥50) |
0.994 (0.973-1.015) |
0.553 |
0.659 (0.315-1.534) |
0.368 |
| Gender (male vs. female) |
1.160 (0.046-2.910) |
0.753 |
1.037 (0.307-3.507) |
0.953 |
| HBsAg (negative vs. positive) |
1.996 (0.622-6.400) |
0.245 |
1.627 (0.383-6.913) |
0.509 |
| HBeAg (negative vs. positive) |
0.929 (0.420-2.054) |
0.856 |
2.457 (0.831-7.262) |
0.104 |
| AFP,ng/ml (≤400 vs. >400) |
1.847 (1.081-3.156) |
0.025 |
3.016 (1.326-6.859) |
0.008 |
| Liver cirrhosis (absent vs. present) |
0.886 (0.493-1.594) |
0.686 |
0.792 (0.341-1.838) |
0.587 |
| Vascular invasion (absent vs. resent) |
2.183 (1.167-4.084) |
0.015 |
4.228 (1.798-9.942) |
0.001 |
| Intrahepatic metastasis (absent vs. present) |
3.674 (2.056-6.566) |
0.000 |
3.079 (1.270-7.764) |
0.013 |
| Tumor size, cm (≤5 vs. >5) |
2.884 (1.358-6.125) |
0.006 |
1.720 (0.644-4.589) |
0.279 |
| Tumor number (single vs. multiple) |
3.464 (1.932-6.211) |
0.000 |
2.622 (1.038-6.622) |
0.041 |
| Differentiation (poor/moderate vs. well) |
1.986 (1.084-3.641) |
0.026 |
3.729 (1.391-10.000) |
0.009 |
| AJCC stage(I-II vs. III-IV) |
3.131 (1.805-5.430) |
0.000 |
5.081 (2.273-11.360) |
0.000 |
| PBLD (low vs. high) |
0.447 (0.260-0.769) |
0.004 |
0.384 (0.165-0.894) |
0.027 |
| Multivariate analysis |
|
|
|
|
| Tumor size, cm (≤5 vs. >5) |
2.839 (1.270-6.345) |
0.011 |
|
|
| AJCC stage (I-II vs. III-IV) |
2.400 (1.137-5.066) |
0.022 |
9.349 (1.754-49.842) |
0.009 |
| PBLD (low vs. high) |
0.502 (0.282-0.891) |
0.019 |
0.364 (0.138-0.957) |
0.040 |
